Blog
RSS FeedPosted by Michael Wonder on 18 Jun 2025
Cancer inhibitors scrapped from basic insurance for some users
18 June 2025 - National health care institute Zorginstituut Nederland has scrapped several cancer inhibiting drugs from the basic health ...
Posted by Michael Wonder on 04 Jan 2024
Applied Therapeutics announces MAA validation and NDA submission of govorestat (AT-007) for treatment of classic galactosaemia
3 January 2024 - Submissions are based on positive results from Phase 3 registrational ACTION-Galactosemia Kids study demonstrating consistent long-term ...
Posted by Michael Wonder on 03 Jan 2024
MHRA’s new international recognition procedure goes live from 1 January 2024
2 January 2024 - In partnership with other global regulators, the international recognition procedure is expected to further help bring life-saving ...
Posted by Michael Wonder on 03 Jan 2024
Theratechnologies submits sBLA for Trogarzo intramuscular method of administration to FDA
2 January 2024 - Submission comes on the heels of the recent FDA approval of the Trogarzo intravenous push loading dose. ...
Posted by Michael Wonder on 03 Jan 2024
Drug makers set to raise US prices on at least 500 drugs in January
29 December 2023 - Drug makers including Pfizer, Sanofi and Takeda plan to raise prices in the United States on ...
Posted by Michael Wonder on 03 Jan 2024
More Americans can now get insulin for $35
2 January 2024 - More Americans with diabetes will get a break on their insulin costs in 2024. ...
Posted by Michael Wonder on 02 Jan 2024
European Medicines Agency validates Bristol Myers Squibb’s application for repotrectinib for the treatment of locally advanced or metastatic ROS1 positive non-small cell lung cancer and NTRK positive solid tumours
2 January 2024 - Application based on data from the registrational TRIDENT-1 and CARE trials showing robust responses and durable activity ...
Posted by Michael Wonder on 02 Jan 2024
Beyfortus approved in China for the prevention of RSV disease in infants
2 January 2024 - First and only RSV preventive option authorised for use in China ...
Posted by Michael Wonder on 02 Jan 2024
Expanded PBS listings make vital treatments more affordable
2 January 2024 - From 1 January 2024, Australians with advanced ovarian cancer, CLL, SLL, cystic fibrosis and atypical haemolytic uraemic ...
Posted by Michael Wonder on 01 Jan 2024
New medical treatments will use genetic scissors, and other clever tricks
13 November 2023 - New medicines to treat sickle cell disease and beta thalassaemia, two genetic blood disorders, will make headlines ...
Posted by Michael Wonder on 01 Jan 2024
New Zealand Pharmaceutical Schedule - 1 January 2024
1 January 2024 - The January 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 01 Jan 2024
How lowering the price of a common asthma drug made it harder to get
29 December 2023 - To avoid Medicaid penalties, Glaxo and other drug makers lowered prices. ...
Posted by Michael Wonder on 01 Jan 2024
PBS medicines to cost Aussies more from today; safety net thresholds also increase
1 January 2024 - Sick Australians who need PBS prescription medicines will be coughing up more from today. ...
Posted by Michael Wonder on 01 Jan 2024
Schedule of Pharmaceutical Benefits - 1 January 2024
1 January 2024 - The January 2024 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 29 Dec 2023
Biden Administration’s Medicare drug price negotiations will face major tests in 2024
28 December 2023 - US patients and drug makers will get a first glimpse of how much Medicare can negotiate down ...
Posted by Michael Wonder on 29 Dec 2023
Father of two has to get cancer treatment in Germany after PHARMAC complications
21 December 2023 - An Auckland man has resorted to treatment for an aggressive bone marrow cancer in Germany after ...